A phase II, single-centre trial of neoadjuvant toripalimab plus chemotherapy in locally advanced esophageal squamous cell carcinoma

BACKGROUND: Esophageal squamous cell carcinoma (ESCC) remains a challenging malignancy with poor prognosis and limited therapeutic methods. However, recent clinical trials of immune checkpoint inhibitors (ICIs) have shown promising results in the treatment of lethal malignancies. The second-line tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Xing, Wenqun, Zhao, Lingdi, Fu, Xiaomin, Liang, Guanghui, Zhang, Yong, Yuan, Dongfeng, Li, Zhenxuan, Gao, Quanli, Zheng, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711391/
https://www.ncbi.nlm.nih.gov/pubmed/33282388
http://dx.doi.org/10.21037/jtd-20-2198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711391/
https://www.ncbi.nlm.nih.gov/pubmed/33282388
http://dx.doi.org/10.21037/jtd-20-2198

Ejemplares similares